{
  "id": "NGN-SA-0045",
  "itemType": "clozeDropdown",
  "caseId": "PEDS-ENDO-012",
  "itemBankId": "NCLEX-RN-2026",
  "version": "1.0",
  "lastUpdated": "2024-05-24T12:00:00Z",
  "author": "NCLEX-RN NGN Content Scientist",
  "difficulty": 4,
  "cjjm": "ANALYZE_CUES",
  "stem": {
    "prompt": "The nurse in the emergency department (ED) is caring for a 78-year-old female brought in by her daughter for progressive lethargy and confusion over the past week. The daughter states the client has been complaining of feeling cold and had a mild upper respiratory infection 10 days ago. The client has a history of atrial fibrillation and hypertension, treated with amiodarone and lisinopril. The nurse completes the initial assessment and reviews the laboratory results.",
    "table": {
      "headers": [
        "Assessment/Lab",
        "Finding"
      ],
      "rows": [
        {
          "cells": [
            "Temperature",
            "95.2° F (35.1° C) rectal"
          ]
        },
        {
          "cells": [
            "Heart Rate",
            "52/min, regular"
          ]
        },
        {
          "cells": [
            "Respiratory Rate",
            "10/min, shallow"
          ]
        },
        {
          "cells": [
            "Blood Pressure",
            "90/60 mmHg"
          ]
        },
        {
          "cells": [
            "SpO2",
            "89% on room air"
          ]
        },
        {
          "cells": [
            "Neurological",
            "Responds to voice, disoriented to time and place, sluggish pupils"
          ]
        },
        {
          "cells": [
            "Skin",
            "Pale, cool, dry with periorbital and pretibial non-pitting edema"
          ]
        },
        {
          "cells": [
            "Arterial Blood Gas (ABG)",
            "pH 7.28, PaCO2 58 mmHg, PaO2 65 mmHg, HCO3 25 mEq/L"
          ]
        },
        {
          "cells": [
            "Sodium",
            "128 mEq/L"
          ]
        },
        {
          "cells": [
            "TSH",
            ">100 mU/L (High)"
          ]
        },
        {
          "cells": [
            "Free T4",
            "0.3 ng/dL (Low)"
          ]
        }
      ]
    },
    "cloze": "The nurse analyzes the client's assessment findings. The client's {blank1} is the most immediate life-threatening concern, primarily caused by {blank2}. This physiological state is further complicated by {blank3}, which contributes to the client's altered mental status."
  },
  "options": [
    {
      "id": "blank3",
      "choices": [
        "hypercapnia-induced narcosis",
        "septic encephalopathy",
        "cerebral hypoxia and hyponatremia",
        "hypoglycemia"
      ]
    },
    {
      "id": "blank1",
      "choices": [
        "respiratory acidosis and hypoxia",
        "profound hypothermia",
        "severe hyponatremia",
        "bradycardia and hypotension"
      ]
    },
    {
      "id": "blank2",
      "choices": [
        "fluid overload from cardiac decompensation",
        "decreased respiratory drive and muscle weakness",
        "amiodarone-induced lung toxicity",
        "metabolic acidosis from lactic acid buildup"
      ]
    }
  ],
  "correctResponse": [
    0,
    1,
    2
  ],
  "answerBreakdown": {
    "scenario": "The scenario presents a 78-year-old female exhibiting signs and symptoms indicative of myxedema coma, a severe manifestation of hypothyroidism. Her history of atrial fibrillation and hypertension, managed with amiodarone and lisinopril, coupled with a recent upper respiratory infection, creates a clinical context for this endocrine emergency. The assessment findings, including hypothermia (35.1°C), bradycardia (52/min), hypotension (90/60 mmHg), hypoventilation (RR 10/min, SpO2 89%), altered mental status, and characteristic myxedematous features (periorbital and pretibial edema), strongly suggest myxedema coma. Laboratory results further support this diagnosis, revealing severe primary hypothyroidism (TSH >100 mU/L, Free T4 0.3 ng/dL), hyponatremia (128 mEq/L), and respiratory acidosis (pH 7.28, PaCO2 58 mmHg, PaO2 65 mmHg).",
    "blank1": {
      "option0": "Correct. The client's arterial blood gas (ABG) results reveal a pH of 7.28 and a PaCO2 of 58 mmHg, indicating respiratory acidosis. The SpO2 of 89% and PaO2 of 65 mmHg confirm concurrent hypoxia. This combination of respiratory acidosis and hypoxia represents an immediate threat to the client's life, as it impairs cellular oxygenation and can rapidly lead to cardiac arrest. The priority is to restore adequate ventilation and oxygenation.",
      "option1": "Incorrect. While a rectal temperature of 95.2° F (35.1° C) signifies significant hypothermia, a hallmark of myxedema coma, it is not the most immediate life-threatening concern. Hypothermia contributes to metabolic slowing and can exacerbate other complications, but the acute respiratory failure poses a more immediate risk of death.",
      "option2": "Incorrect. A sodium level of 128 mEq/L indicates hyponatremia, which can contribute to altered mental status and increase the risk of seizures. However, it is not as immediately life-threatening as the respiratory compromise. Hyponatremia needs to be addressed, but after stabilizing the client's respiratory status.",
      "option3": "Incorrect. Bradycardia (HR 52/min) and hypotension (BP 90/60 mmHg) are concerning findings that reflect cardiovascular instability in myxedema coma. However, these are secondary to the underlying metabolic derangement and respiratory failure. Addressing the respiratory acidosis and hypoxia is paramount to improving cardiovascular function."
    },
    "blank2": {
      "option0": "Incorrect. While cardiac decompensation can occur in myxedema coma, the primary respiratory problem in this scenario is hypoventilation, as evidenced by the elevated PaCO2. Fluid overload is not the primary driver of the respiratory distress.",
      "option1": "Correct. Myxedema coma is characterized by a profound decrease in metabolic rate, which directly affects the central nervous system (CNS). This leads to a blunted respiratory drive from the brainstem, resulting in hypoventilation. Additionally, the metabolic slowing causes muscle weakness, including the respiratory muscles (diaphragm and intercostals), further impairing the ability to maintain adequate ventilation. This combination of decreased respiratory drive and muscle weakness leads to shallow breathing (bradypnea) and retention of CO2, causing respiratory acidosis.",
      "option2": "Incorrect. Amiodarone can cause pulmonary toxicity, but this typically presents as a chronic, fibrotic process with dyspnea and cough over time. The client's acute presentation is more consistent with myxedema-induced respiratory failure, rather than a chronic drug side effect.",
      "option3": "Incorrect. The arterial blood gas (ABG) results clearly indicate a primary respiratory acidosis (elevated PaCO2), not metabolic acidosis. While severe shock can lead to secondary lactic acidosis, the initial cause of the client's respiratory failure is hypoventilation due to the metabolic derangement of myxedema coma. The bicarbonate level (HCO3) is within normal limits, further supporting the diagnosis of respiratory acidosis."
    },
    "blank3": {
      "option0": "Incorrect. While hypercapnia (elevated PaCO2) contributes to lethargy and confusion through CO2 narcosis, this option is incomplete. It does not fully account for the significant roles of cerebral hypoxia (PaO2 65 mmHg) and hyponatremia (Na+ 128 mEq/L) in causing the client's profound neurological decline.",
      "option1": "Incorrect. Although the client had a recent upper respiratory infection, which may have acted as a trigger for the myxedema coma, there are no specific signs of active systemic infection or sepsis (e.g., fever, leukocytosis) to support a diagnosis of septic encephalopathy. The altered mental status is better explained by the metabolic derangements of myxedema.",
      "option2": "Correct. The client's altered mental status is multifactorial, resulting from the combined effects of cerebral hypoxia and hyponatremia. The brain is highly sensitive to both oxygen deprivation and electrolyte imbalances. The low PaO2 of 65 mmHg signifies cerebral hypoxia, impairing neuronal function. The low sodium of 128 mEq/L causes a fluid shift into brain cells, leading to cerebral edema and further neurological impairment. This combination of hypoxia and hyponatremia is a primary driver of the severe neurological impairment seen in myxedema coma.",
      "option3": "Incorrect. The client's blood glucose level is not provided in the data table. While hypoglycemia can occur in myxedema coma and cause altered mental status, it cannot be identified as the complicating factor without a specific value. The known data points of hypoxia and hyponatremia provide a direct and sufficient explanation for the client's condition."
    }
  },
  "scoring": {
    "type": "DIAD",
    "points": 1
  },
  "sbar": {
    "situation": "0700: 78-year-old female presenting with progressive lethargy and confusion. History of atrial fibrillation and hypertension, treated with amiodarone and lisinopril. Possible recent URI.",
    "background": "Daughter reports progressive lethargy and confusion over the past week. Client has been complaining of feeling cold. History of atrial fibrillation and hypertension, treated with amiodarone and lisinopril. Recent upper respiratory infection 10 days ago.",
    "assessment": "0715: T 95.2° F (35.1° C) rectal, HR 52/min regular, RR 10/min shallow, BP 90/60 mmHg, SpO2 89% on room air. Responds to voice, disoriented to time and place, sluggish pupils. Pale, cool, dry skin with periorbital and pretibial non-pitting edema. ABG: pH 7.28, PaCO2 58 mmHg, PaO2 65 mmHg, HCO3 25 mEq/L. Sodium 128 mEq/L, TSH >100 mU/L, Free T4 0.3 ng/dL.",
    "recommendation": "0720: Anticipate need for intubation and mechanical ventilation due to respiratory acidosis and hypoxia. STAT orders recommended: IV levothyroxine and hydrocortisone. Continuous cardiac monitoring. Frequent vital sign monitoring. Address hyponatremia cautiously. Consider further investigation (CT head) to rule out other causes of altered mental status if no improvement with initial treatment. Notify attending physician immediately."
  },
  "clinicalPearls": [
    "Myxedema coma is a life-threatening complication of severe hypothyroidism requiring prompt recognition and treatment.",
    "Amiodarone is known to induce hypothyroidism; patients on amiodarone should have thyroid function monitored regularly.",
    "Hypothermia in myxedema coma can be profound and easily overlooked; use a low-reading thermometer and consider rectal temperature measurement.",
    "Respiratory failure is a common and life-threatening complication of myxedema coma; be prepared for intubation and mechanical ventilation.",
    "Hyponatremia is frequently present in myxedema coma and contributes to altered mental status; correct slowly to avoid osmotic demyelination syndrome."
  ],
  "sentinelStatus": "healed_v2026_v8"
}